Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)

Market Cap	798.29M -39.7%
Revenue (ttm)	879.03M +243.8%
Net Income	131.91M
EPS	0.23
Shares Out	570.21M
PE Ratio	6.09
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	101,785,800
Average Volume	37,845,428
Open	1.330
Previous Close	1.330
Day's Range	1.330 - 1.490
52-Week Range	0.808 - 4.110
Beta	0.29
RSI	58.17
Earnings Date	Feb 26, 2026

About EGX:MCRO

Macro Group Pharmaceuticals (Macro Capital) S.A.E operates as a cosmeceuticals manufacturing company in Egypt and internationally. It engages in the production of pharmaceutical and cosmetic products, such as skin care, hair care, oral care, female intimate care, anti-scar, antiseptics, and topical muscle relaxants, as well as flavors, colors, and scents. The company also manufactures solid and liquid soap, herbal medicines, products and extracts, nutritional supplements, baby food, and special food products. It also offers its products online....

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2002
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MCRO

Financial Performance

In 2024, EGX:MCRO's revenue was 519.97 million, a decrease of -1.15% compared to the previous year's 526.01 million. Losses were -38.10 million, -86.03% less than in 2023.